Overview

Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients

Status:
Completed
Trial end date:
2017-08-08
Target enrollment:
Participant gender:
Summary
This trial evaluated the efficacy and safety of Everolimus in combination with tacrolimus versus a standard immunosuppressive regimen concerning kidney function in liver transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Collaborator:
Winicker Norimed GmbH
Treatments:
Everolimus
Sirolimus
Tacrolimus